ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS
This is a Phase III, multi-centre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- RAPA-501 Therapy of ALS Expanded Access Protocol#881278
- Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease#1033608
- Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma#1163499
- A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study#846869
- Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS#892259
Record · ID 1085591
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive